Limited Time Sale: Get OneTest™ for 20% Off!
The sale is valid through June 19th

OneTest™ for Cancer

An Affordable, Accurate Multi-Cancer Early Detection
Blood Test Now Available for Your Employees

OneTest™ for Cancer

An Affordable, Accurate Multi-Cancer Early Detection Blood Test Now Available for Your Employees  

Multi-Cancer Early Detection (MCED) blood testing is a hot healthcare topic in 2022,. The White House Cancer Moonshot, the U.S. National Cancer Institute, and American Cancer Society are all engaged in this exciting new screening approach.

OneTest™ for Cancer, which has been ordered by over 100 American employers and used by thousands of individuals across the country, is the only marketed MCED blood test available for as low as $149. Here’s why your company should offer your  employees OneTest™ for Cancer: 

OneTest™, when included as part of an annual screening and wellness program, can help detect many cancers at an early stage, thus saving employee lives and sparing the significant costs and burdens of very expensive drug treatments for advanced disease, which often provide only marginal benefit to the patient.

Contact Us for a Free Consultation

We would love to hear from you. Please complete the form below and we will get back to you as soon as possible.
 

The Numbers Behind OneTest™ for Cancer

0 %
of employees want to find out as early as possible if they have cancer 1
# 1 top ranked health benefit
Employees say an early cancer detection test ranks as important as 401(k) matching as a health benefit.1
0 +
Employers used OneTest™ for Cancer since 2020
0 +
Individuals have been tested since 2020
0 +
OneTest™ help detect over 20 types of cancer

Footnotes:

  1. Galleri for Employers. (2022, October 20). Galleri®. https://www.galleri.com/employers
Shopping Basket